Data as of 9:38am ET
| -0.0899 / -1.81%|
The 1 analysts offering 12-month price forecasts for Nymox Pharmaceutical Corp have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +84.05% increase from the last price of 4.89.
The current consensus among 1 polled investment analysts is to Buy stock in Nymox Pharmaceutical Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.